CRA RheumReview

Join us virtually for CRA RheumReview on Feb 21, 2025.

Refresh your knowledge with a high-yield educational program on clinically relevant topics!

CRA RheumReview: Canadian Clinical Updates (formerly CRA Review Course) is a full-day virtual event designed for practicing rheumatologists interested in updating their knowledge on hot topics within the rheumatology world. CRA RheumReview is available to CRA members and non-members.

The primary objective of this program is to provide attendees with evidence-based, clinical updates on important conditions seen by rheumatologists. CRA RheumReview features presentations by Canadian and international experts and provides pearls on various core clinical rheumatology topics and diseases through a Canadian lens.

RheumReview is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Rheumatology Association (CRA).

At the end of the RheuReview program, participants will be able to:

  1. Apply new approaches to assessment and diagnosis for common rheumatic diseases in clinical practice
  2. Optimize novel therapies and therapeutic strategies for patients with common rheumatic diseases in clinical practice
  3. Gain awareness of the pipeline for future developments in the management of common rheumatic diseases

Session Learning Objectives

Rheumatoid Arthritis Management in Patients with Cancer
David Liew

This session will address how to navigate the management of rheumatoid arthritis in patients with cancer, including the potential impact of RA therapies on cancer recurrence and cancer therapy efficacy.

At the end of this session, participants will be able to:

  1. Manage risk related to DMARDs in the context of existing cancer
  2. Appreciate the reasoning behind recent guidance for RA patients with cancer
  3. Understand special considerations in RA management related to immune checkpoint inhibitor therapy

CanMEDS roles

  1. Medical Expert
  2. Collaborator
  3. Health Advocate
  4. Scholar
  5. Professional

Update on Dermatomyositis and Antisynthetase Syndrome
Kun Huang

This presentation explores the evolving clinical paradigm in the diagnosis and management of dermatomyositis and antisynthetase syndrome. With a focus on recent advancements in clinical assessment, we will examine the role of nailfold capillaroscopy and autoantibodies in improving diagnostic accuracy. Additionally, we will review emerging therapies and ongoing clinical trials that are shaping the future of treatment for inflammatory myositis, offering new hope for improved patient outcomes.

At the end of this session, participants will be able to:

  1. Discuss the evolving clinical paradigm in dermatomyositis and antisynthetase syndrome
  2. Address the latest advancements in clinical assessment and the role of autoantibodies.
  3. Review the emerging therapies and clinical trials for inflammatory myositis.

CanMEDS roles

  1. Medical Expert
  2. Collaborator
  3. Health Advocate
  4. Scholar

How to Manage Soft Tissue Residual Pains in Well Controlled Inflammatory Patients in an Office Setting
Max Sun

This session will address the underlying nature of chronic soft tissue pains and the steps you can take to treat patients with this condition.

At the end of this session, participants will be able to:

  1. Recognize widespread soft tissue pains in the office
  2. Demonstrate a time efficient approach to dealing patients in inflammatory disease remission
  3. Initiate first steps to treat these patients and identify when to consider referral to a pain clinic

CanMEDS roles

  1. Communicator
  2. Collaborator
  3. Health Advocate

What Rheumatologists Should Know About Autoimmune Bowel Diseases
Christopher Ma

This session will give a rapid update on major advances in Crohn’s disease, ulcerative colitis, and immunotherapy-induced colitis.

At the end of this session, participants will be able to:

  1. Discuss the assessment of patients with IBD
  2. Review therapeutic advances in IBD in 2024
  3. Describe updates in immune checkpoint inhibitor therapy induced colitis

CanMEDS roles

  1. Medical Expert
  2. Collaborator
  3. Scholar

Autoinflammatory Disease: When to Consider and How to Investigate
Hugues Allard-Chamard

This session will focus on autoinflammatory disorders in adults and their presentation as well as their targeted treatments. The participant will learn on how to investigate auto inflammatory syndrome and how autoinflammation can be part of some polygenic disorders.

At the end of this session, participants will be able to:

  1. Identify key features in each category of autoinflammatory disorders
  2. Recognize the main treatment used for auto inflammatory disorder
  3. Describe how the presence of auto inflammation affects the development and manifestation of polygenic disorders

CanMEDS roles

  1. Medical Expert
  2. Communicator
  3. Health Advocate

Approach to Cutaneous Lupus for the Rheumatologist
Victoria Werth

This presentation will review clinical findings of cutaneous lupus erythematosus, the work-up of such patients, and approaches to treatment.

At the end of this session, participants will be able to:

  1. Recognize the most common skin manifestations of cutaneous lupus
  2. Identify the implications for testing for co-morbidities in patients with CLE
  3. Utilize the treatment algorithms most commonly used in patients with CLE

CanMEDS roles

  1. Medical Expert
  2. Communicator
  3. Collaborator

Please click here to view schedule.

  • Open to CRA members and non-members
  • Save 50% off RheumReview registration when you register for the CRA Annual Scientific Meeting (ASM)
  • The 50% discount promo code will be sent in the 2025 CRA Annual Scientific Meeting Confirmation email once ASM registration has been processed
  • Prices go up by $125 one week before for each category (Late Fees). Late registration requests must be sent to info@rheum.ca.
  • Please click here to view the Refund Policy and Registration Disclaimer.

Registration Fees

Early Bird Deadline: Dec. 13, 2024

Registration Fees Virtual RheumReview Save 50% RheumReview registration when you register for the CRA Annual Scientific Meeting (ASM)*
Registration Type Early Bird After Dec. 13 Register for the CRA ASM and save
CRA Member $390 $550 50% OFF
CRA Member Trainee $200 $360 50% OFF
AHPA Member $200 $330 50% OFF
Residents/CRA Summer Students/Post Docs/Medical Students $200 $330 50% OFF
Non-member (non-industry) $520 $680 50% OFF
Sponsor Rep
(scientific/medical division) Must be a CRA-approved corporate sponsor. Email us for pre-approval.
$920 $1100

*Save 50% off RheumReview registration when you register for the CRA Annual Scientific Meeting (ASM)! Once you have registered for the ASM, a RheumReview promo code will be sent in the 2025 CRA ASM confirmation email.

Registration closes Jan. 31, 2025, at 11:59 p.m. ET.

CRA members: Please log in with the email address associated with your CRA membership.

Registration information:

  • Open to CRA members and non-members
  • Save 50% RheumReview registration when you register for the CRA Annual Scientific Meeting

CRA members: please log in with the email address associated with your CRA membership to receive your registration discount.

TESTIMONIALS

“A very good mix of clinical and high-yield topics.  It is always great to hear from our national experts, with a few international experts as well.  I’m looking forward to seeing what is in store for 2024…”

Dr. Dana Jerome, Toronto, Ontario

“This program is a fantastic return of investment for both time and money!  The curricular content is current, and the experts who lead the sessions are top-notch. I strongly recommend the course.”

Dr. Evelyn Sutton, Halifax, Nova Scotia

“I appreciate the program’s focus on clinically relevant rheumatology updates. This program helps me identify and eliminate important knowledge gaps; I learn something new with each presentation!”

Dr. Kam Shojania, Vancouver, British Columbia

“A great resource with many practical insights that can be applied in community rheumatology practice.”

Dr. Jason Kur, Vancouver, British Columbia